NDC 17772-131 – Qelbree
Viloxazine Hydrochloride 100 mg/1 · Capsule, Extended Release · Oral
Product NDC17772-131
Product details
- Brand name
- Qelbree
- Generic name
- viloxazine hydrochloride
- Labeler
- Supernus Pharmaceuticals, Inc
- Dosage form
- Capsule, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA211964
- Marketed since
- April 2, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Norepinephrine Reuptake Inhibitor
Active ingredients
- Viloxazine Hydrochloride 100 mg/1
Package NDC codes (5)
| Package NDC | Description | Since |
|---|---|---|
| 17772-131-01 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-01) | Apr 2, 2021 |
| 17772-131-07 sample | 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-07) | Apr 2, 2021 |
| 17772-131-30 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-30) | Apr 2, 2021 |
| 17772-131-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-60) | Apr 2, 2021 |
| 17772-131-90 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-90) | Apr 2, 2021 |